GRFS · Grifols SA · Webcasts, Transcripts & Audio
$8.15
-0.05 (-0.61%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$5.55B
Shares
680.58M
Volume · Nov 20
848.3K
Avg daily vol (3M)
622.34K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Grifols SA Webcasts
Earnings calls, investor updates, investor days and conferences for Grifols SA (GRFS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-02
Grifols SA (GRFS) Q3 2026 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-28
Grifols SA (GRFS) Q2 2026 Earnings Call Transcript
Confident tone
Albumin stabilization in China
Plasma sourcing and self-sufficiency
Financial profile and cash generation
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Grifols SA (GRFS) Q1 2026 Earnings Call Transcript
Positive tone
Albumin in China headwinds
Egypt plasma platform and global sourcing optimization
Balance sheet and refinancing
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Grifols SA (GRFS) Q4 2025 Earnings Call Transcript
Confident tone
Egypt and Canada self-sufficiency projects
Cash flow generation and deleveraging
Immunoglobulin growth and market share
No reported figures on file
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Grifols SA (GRFS) Q3 2025 Earnings Call Transcript
Positive tone
Free cash flow generation
Margin expansion and EBITDA
Fibrinogen pipeline
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Grifols SA (GRFS) Q2 2025 Earnings Call Transcript
Confident tone
Commercial growth / Biopharma momentum
Free cash flow & deleveraging
Pipeline execution & fibrinogen launch
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Grifols SA (GRFS) Q1 2025 Earnings Call Transcript
Positive tone
Q1 2025 Financial Performance
Albumin Market and Phasing
Fibrinogen Launch
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Grifols SA (GRFS) Q1 2024 Earnings Call Transcript
Positive tone
Free cash flow generation
Debt management and deleveraging
Biopharma and plasma business momentum
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Grifols SA (GRFS) Q4 2023 Earnings Call Transcript
No reported figures on file
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Grifols SA (GRFS) Q3 2023 Earnings Call Transcript
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Grifols SA (GRFS) Q2 2023 Earnings Call Transcript
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Grifols SA (GRFS) Q1 2023 Earnings Call Transcript
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Grifols SA (GRFS) Q4 2022 Earnings Call Transcript
No reported figures on file
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Grifols SA (GRFS) Q3 2022 Earnings Call Transcript
No reported figures on file
Audio
Transcript
Slides
8-K10-Q
Showing 1–14 of 14 webcasts
Key facts
CIK
1438569
CUSIP
398438408
13F (30d)
181 filings
153 filers
Visit website
Investor relations